Fuxing Tang

Fuxing Tang's work experience begins in 2002 at Allergan, where they served as the Director of Pharmaceutical Sciences/Preclinical Sciences until 2017. From 2017 to 2018, they worked as the Director of Pharmaceutical Sciences/Preclinical Sciences at Teva Pharmaceuticals. In 2018, they joined the FDA as a Senior Reviewer until 2020. Currently, Fuxing Tang holds the position of Chief Technology Officer at Hua Medicine and is also the President of Hua Medicine USA INC.

Fuxing Tang obtained a Ph.D. in Pharmaceutical Science from the University of Florida, where they studied from 1997 to 2000. Following this, they pursued further studies as a post-doctoral fellow at The University of Kansas from 2000 to 2002.